Ask AI
ProCE Banner Events

Share

Test First, Treat Right: Advancing ROS1 Detection and Targeted Therapy Selection in NSCLC

Explore best practices for ROS1 testing and targeted therapy selection in NSCLC, including strategies to improve detection and apply emerging evidence to individualized treatment decisions. Gain practical insights for integrating accurate molecular testing and ROS1-targeted therapies across the care continuum.

Physicians ABIM MOC: maximum of 1.00 Medical Knowledge MOC point

Physicians: maximum of 1.00 AMA PRA Category 1 Credit

Physician Assistants/Physician Associates: 1.00 AAPA Category 1 CME credit

Pharmacists: 1.00 contact hour (0.1 CEUs)

Nurse Practitioners/Nurses: 1.00 Nursing contact hour

Who Should Attend

Oncologists, nurse practitioners, physician associates, pharmacists, nurses, and other HCPs caring for patients with non-small-cell lung cancer or thoracic cancer. 

Time and location

Wednesday, September 02, 2026

4:30 PM - 5:30 PM Eastern Time (ET)

Virtual

Agenda

  • Comprehensive Genomic Profiling for Gene Fusions in NSCLC
  • Integrating Approved Targeted Agents Into Clinical Practice for NSCLC
  • Investigational Fusion Protein–Targeted Agents for Thoracic Cancers: An Optimistic Outlook
  • Panel Discussion/Audience Q&A

CME/CE Info

Goal Statement
The goal of this activity is to improve the learners’ knowledge, confidence, and competence in caring for patients with thoracic malignancies who are candidates for fusion protein–targeted therapy.

Target Audience
Oncologists, nurse practitioners, physician associates, pharmacists, nurses, and other HCPs caring for patients with non-small-cell lung cancer or thoracic cancer. 

Learning Objectives
Upon completion of this activity, participants should be able to:

  •  Implement appropriate molecular testing strategies to accurately identify patients with NSCLC harboring ROS1 rearrangements and other actionable oncogenic drivers

  • Select evidence-based targeted therapies for patients with ROS1-positive NSCLC based on biomarker findings, disease characteristics, current clinical data, and established treatment guidelines

  • Develop and optimize multidisciplinary workflows that support timely comprehensive biomarker testing and accurate detection of ROS1 rearrangements in patients with NSCLC

Accreditation

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC dba Decera Clinical Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Physician Continuing Medical Education

Clinical Care Options, LLC dba Decera Clinical Education designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Professional Development

The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 1.0 contact hour.

Continuing Pharmacy Education

Clinical Care Options, LLC dba Decera Clinical Education designates this continuing education activity for 1.0 contact hour (0.10 CEUs) of the Accreditation Council for Pharmacy Education. Universal Activity Number: JA4008176-0000-26-442-L01-P 

Type of Activity: Application

Upon successfully completing the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 60 days.

Physician Associate Continuing Medical Education

Clinical Care Options, LLC dba Decera Clinical Education has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credit. PAs should only claim commensurate with the extent of their participation.

American Board of Internal Medicine Maintenance of Certification

Title: A blue and black sign with white textDescription automatically generated

Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn up to 1.0 MOC point in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABIM MOC credit.

For ABIM MOC points, your information will be shared with the ABIM through Decera Clinical Education’s Joint Accreditation Program and Activity Reporting System (JAPARS). Please allow 6-8 weeks for your MOC points to appear on your ABIM records.

By sharing your Diplomate Board ID # and DOB, you are giving Decera Clinical Education permission to use this information/data to report your participation to these Boards via the Joint Accreditation Program and Activity Reporting System (JA-PARS).

IPCE Credit Designation

https://omni-channel-2022-assets-production.s3.amazonaws.com/editorupload/657115052be04.jpg

This activity was planned by and for the healthcare team, and learners will receive 1.0 Interprofessional Continuing Education (IPCE) credit for learning and change.

CME Passport

The CME credits that physicians earn from this activity will be submitted to ACCME's CME Passport, a free, centralized web application where you can create a personalized account to view, track, and generate transcripts of your reported CME credit. Visit www.cmepassport.org to create your account.

Disclosure of Conflicts of Interest
Decera Clinical Education requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to Decera Clinical Education policy. Decera Clinical Education is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

Acknowledgement

Provided by

Provided by Clinical Care Options, LLC dba Decera Clinical Education

Clinical Care Options, LLC dba Decera Clinical Education

Supporter

This activity is supported by an educational grant from Nuvation Bio Inc.

Nuvation Bio Inc.

Contact Information

For customer support please click here.

Mailing Address:

 

Decera Clinical Education
12001 Sunrise Valley Drive
Suite 304
Reston, VA 20191

 

Additional Information

There are no fees required to participate in this activity.

Americans With Disabilities Act
Event staff will be glad to assist you with any special needs (eg, physical, dietary). Please contact Customer Support prior to the live event.